ICU Medical, Inc.
- ICUI
- NASDAQ
- Medical - Instruments & Supplies
- Infusion Therapy Devices
- Critical Care Products
$161.24
Today −1.07%Quote Oct 19, 2026, 08:00 PM UTC
+5.63%over the last month
Max drawdown −6.0%From 1-month high −3.6%3 months +1.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About ICU Medical
ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands.
Where the money comes from
Q2 2026 revenue $551.7M
- Equipment revenue$76.6M13.9%
- Software revenue$18.6M3.4%
- Other deferred revenue$1.3M0.2%
- Other / not reported$455.1M82.5%
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Exchange
NASDAQ
Employees
13,000
Market value
$4.03B
Quote Oct 19
Floor
$159.09
1.3% below price
Resistance
$162.71
0.9% above price
Price vs analyst targets
12 analysts
Lowest target
$182.00Highest target
$200.00
$182.00Highest target
$200.00
- Price $161.24
- Average target $192.25
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 19% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ICUIPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free